Tag
A study from King's College London reveals that hospitals and universities are conducting late-stage clinical trials for repurposing generic drugs at less than 10% of pharmaceutical companies' costs, offering affordable treatments for conditions like blindness, cancer prevention, and Covid.
Virtual health is expanding healthcare access globally, with case studies from Saudi Arabia to the US, potentially reducing the projected $47 trillion economic burden by 2030.